-+ 0.00%
-+ 0.00%
-+ 0.00%

XORTX Therapeutics elects to voluntarily delist from TSX Venture Exchange

PUBT·06/12/2026 21:00:20
Listen to the news
XORTX Therapeutics elects to voluntarily delist from TSX Venture Exchange
  • XORTX elected to voluntarily delist its common shares from the TSX Venture Exchange on June 12, 2026.
  • Move follows a review that found the dual TSXV-Nasdaq listing did not justify added costs, administration, and regulatory complexity.
  • Trading access remains via Nasdaq, including for Canadian shareholders; no shareholder action required.
  • XORTX flagged a separate press release to provide timing for completion of the TSXV delisting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XORTX Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606121700PRIMZONEFULLFEED9746406) on June 12, 2026, and is solely responsible for the information contained therein.